Elan Pharmaceuticals has developed Myocet , a non-PEGylated liposomal formulation of doxorubicin (NPLD), which has demonstrated reduced cardiotoxicity and enhanced bioavailability
The primary analysis used ANCOVA to estimate the effect of treatment (semaglutide vs
In this review, we discuss the pipeline of obesity pharmacotherapies with focus on entero-pancreatic hormone-based molecules, and we evaluate the data from early and late phase clinical trials on their safety and efficacy on WL in people with and without T2D
Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ
The 'Wild West' Marketplace: Contamination and Counterfeits Because these peptides are not FDA-approved, they are manufactured in unregulated labs and sold as 'research chemicals not for human consumption' a transparent legal loophole